Belite Bio Q2 EPS $(0.50) Misses $(0.40) Estimate

Belite Bio (NASDAQ: BLTE) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.40) by 25.63 percent. This is a 92.31 percent decrease over losses of $(0.26) per share from the same period last year.